Gimme Health advertises compounded tirzepatide at $199/month according to Reddit reports captured September 4, 2026, but no prepaid or multi-month plan evidence exists in available sources. This article explains the evidence gap and what can be confirmed.

Willow charges $299/month for compounded semaglutide and $399/month for tirzepatide, billed monthly with no prepaid options documented. We compare these rates to PlexusDx month-to-month and prepaid plans, showing 12-month costs and per-dose economics.

Belle offers month-to-month billing and prepaid 2-month or 6-month plans for both semaglutide and tirzepatide. The 6-month plan cuts the effective per-month cost by 32–40% over monthly billing, but requires upfront payment and a 6-month commitment.

Mochi Health publishes only monthly billing at starting doses; PlexusDx offers month-to-month and prepaid (3-month, 6-month) options with flat pricing at every dose and no membership fee.

Noom Med's quarterly Core program bills $387 every three months after the first month, while its Microdose GLP-1Rx runs monthly with an introductory period—but the evidence shows structural gaps that make a clean monthly-versus-prepaid comparison harder than it looks.

OatMeds' prepaid bundles deliver lower per-month rates, but PlexusDx offers month-to-month flexibility with no upfront commitment. Here's how to make the switch without a gap in treatment.

Fifty410 underprices PlexusDx on tirzepatide by prepaying three months at a time. For semaglutide month-to-month, PlexusDx costs $10 less per month.

Fifty410 charges $199/month for semaglutide vs PlexusDx $189/month; tirzepatide requires $399–$549 upfront every three months at Fifty410 vs $289/month at PlexusDx with no prepayment.